These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15311108)

  • 1. Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats.
    Nishikimi T; Akimoto K; Wang X; Mori Y; Tadokoro K; Ishikawa Y; Shimokawa H; Ono H; Matsuoka H
    J Hypertens; 2004 Sep; 22(9):1787-96. PubMed ID: 15311108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
    Koshikawa S; Nishikimi T; Inaba C; Akimoto K; Matsuoka H
    J Hypertens; 2008 Sep; 26(9):1837-48. PubMed ID: 18698220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats.
    Nishikimi T; Koshikawa S; Ishikawa Y; Akimoto K; Inaba C; Ishimura K; Ono H; Matsuoka H
    J Hypertens; 2007 May; 25(5):1053-63. PubMed ID: 17414670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats.
    Ishikawa Y; Nishikimi T; Akimoto K; Ishimura K; Ono H; Matsuoka H
    Hypertension; 2006 Jun; 47(6):1075-83. PubMed ID: 16636194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effect of rho-kinase inhibitor in hypertensive glomerulosclerosis.
    Nishikimi T; Matsuoka H
    J Pharmacol Sci; 2006 Jan; 100(1):22-8. PubMed ID: 16397372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats.
    Mita S; Kobayashi N; Yoshida K; Nakano S; Matsuoka H
    J Hypertens; 2005 Jan; 23(1):87-96. PubMed ID: 15643129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats.
    Kanda T; Wakino S; Hayashi K; Homma K; Ozawa Y; Saruta T
    Kidney Int; 2003 Dec; 64(6):2009-19. PubMed ID: 14633123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.
    Gojo A; Utsunomiya K; Taniguchi K; Yokota T; Ishizawa S; Kanazawa Y; Kurata H; Tajima N
    Eur J Pharmacol; 2007 Jul; 568(1-3):242-7. PubMed ID: 17511984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Rho-kinase inhibitor, fasudil, attenuates progressive glomerulosclerosis induced by daunorubicin in rats.
    Deng B; Yang X; Zhu Z; Zhang C
    J Huazhong Univ Sci Technolog Med Sci; 2009 Dec; 29(6):720-4. PubMed ID: 20037814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats.
    Nishikimi T; Mori Y; Kobayashi N; Tadokoro K; Wang X; Akimoto K; Yoshihara F; Kangawa K; Matsuoka H
    Hypertension; 2002 Jun; 39(6):1077-82. PubMed ID: 12052845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renoprotective effect of long-term combined treatment with adrenomedullin and omapatrilat in hypertensive rats.
    Ishimura K; Nishikimi T; Akimoto K; Ono H; Kangawa K; Matsuoka H
    J Hypertens; 2005 Dec; 23(12):2287-96. PubMed ID: 16269971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCepsilon-MAPK-p90RSK, and Rho-kinase pathway.
    Kobayashi N; Hara K; Tojo A; Onozato ML; Honda T; Yoshida K; Mita S; Nakano S; Tsubokou Y; Matsuoka H
    Hypertension; 2005 Apr; 45(4):538-44. PubMed ID: 15710785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effect of a combination of Rho-kinase inhibitor and p38 MAPK inhibitor on cardiovascular remodeling and oxidative stress in Dahl rats.
    Takeshima H; Kobayashi N; Koguchi W; Ishikawa M; Sugiyama F; Ishimitsu T
    J Atheroscler Thromb; 2012; 19(4):326-36. PubMed ID: 22166971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
    Li F; Xia W; Li A; Zhao C; Sun R
    Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury.
    Sun GP; Kohno M; Guo P; Nagai Y; Miyata K; Fan YY; Kimura S; Kiyomoto H; Ohmori K; Li DT; Abe Y; Nishiyama A
    J Am Soc Nephrol; 2006 Aug; 17(8):2193-201. PubMed ID: 16790507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
    Wang YX; da Cunha V; Martin-McNulty B; Vincelette J; Li W; Choy DF; Halks-Miller M; Mahmoudi M; Schroeder M; Johns A; Light DR; Dole WP
    Eur J Pharmacol; 2005 Apr; 512(2-3):215-22. PubMed ID: 15840407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms and therapeutic strategies of chronic renal injury: role of rho-kinase in the development of renal injury.
    Hayashi K; Wakino S; Kanda T; Homma K; Sugano N; Saruta T
    J Pharmacol Sci; 2006 Jan; 100(1):29-33. PubMed ID: 16397371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of the Rho/Rho-kinase pathway in the development of hypertensive glomerulosclerosis: renoprotective effect of Rho-kinase inhibitor in hypertensive glomerulosclerosis and its molecular mechanism].
    Nishikimi T
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):153-9, 152. PubMed ID: 16971778
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
    Li Q; Xu Y; Li X; Guo Y; Liu G
    Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in Arhgef11 are associated with kidney injury in the Dahl salt-sensitive rat.
    Williams JM; Johnson AC; Stelloh C; Dreisbach AW; Franceschini N; Regner KR; Townsend RR; Roman RJ; Garrett MR
    Hypertension; 2012 Nov; 60(5):1157-68. PubMed ID: 22987919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.